Clinical Features,Oseltamivir Treatment and Outcome in Infants Aged <12 Months with Laboratory-Confirmed Influenza a in 2009

Abstract

Background

Data on the use of oseltamivir in infants is limited. We documented the clinical presentations of infants aged <12 months hospitalized with laboratory-confirmed influenza A in the southern hemisphere winter of 2009 and compared outcomes in relation to oseltamivir therapy.

Methods

Data were extracted from prospectively collected and collated influenza case reports (June– September 2009) ascertained through Paediatric Active Enhanced Disease Surveillance, an in-patient surveillance system operating at the Children's Hospital at Westmead (CHW), Sydney, NSW, Australia. Nosocomial cases were excluded.

Results

Of 56 infants with definite influenza (35 pandemic H1N1 2009) admitted to the CHW, 20 were treated with oseltamivir. Overall, 12 (60%) of those treated with oseltamivir were aged <6 months. Cough, fever and coryza were the most common clinical features (≥70%). Vomiting was present on admission in 31.4%. All 7 cases presenting with vomiting then given antiviral treatment had reduction of vomiting and the other 13 did not develop vomiting on treatment. There were three infants with hypoxaemia (oxygen saturation ≤93%) on presentation in the treatment group compared with none in the control group (P=0.04). The median duration of hospital stay was the same in both groups (2.5 days).

Conclusions

The use of oseltamivir was well tolerated in hospitalized infants. Vomiting, one of the widely reported side effects of oseltamivir, was found to be more a presenting symptom of influenza than a side effect of oseltamivir. Based on pulse oximetry, oseltamivir-treated cases may have been more severe on presentation, but there was no significant difference in length of hospital stay.

References

Centres for Disease Control and Prevention. Update: novel influenza A (H1N1) virus infections – worldwide, May 6, 2009. MMWR Morb Mortal Wkly Rep 2009; 58: 453–458.

Fraser

, Donnelly

C.A.

, Cauchemez

Pandemic potential of a strain of influenza A (H1N1): early findings. Science 2009; 324: 1557–1561.

World Health Organization. Pandemic (H1N1) 2009 – update 97. (Updated 23 April 2010. Accessed 25 April 2010.) Available from http://www.who.int/csr/don/2010_04_23a/en/index.html.

The ANZIC Influenza Investigators. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009; 361: 1925–1934.

Sachedina

, Donaldson

L.J.

Paediatric mortality related to pandemic influenza A H1N1 infection in England: an observational population-based study. Lancet 2010; 376: 1846–1852.

US Food and Drug Administration. Emergency dosing recommendations for treatment and prophylaxis of influenza in pediatric patients less than 1 year old. (Updated 18 May 2009. Accessed 22 January 2010.) Available from http://www.fda.gov/downloads/Drugs/DrugSafety/InformationbyDrugClass/UCM153546.pdf.

Siedler

, Skopnik

Oseltamivir for treatment of influenza in infants less than one year: a retrospective analysis. Pediatr Infect Dis J 2010; 29: 495–498.

Tamura

, Miura

, Kikuchi

Oseltamivir phosphate in infants under 1 year of age with influenza infection. Pediatr Int 2005; 47: 484.

Okamoto

, Kamiya

, Kishida

, Shimakawa

, Fukui

, Morimoto

Experience with oseltamivir for infants younger than 1 year old in Japan. Pediatr Infect Dis J 2005; 24: 575–576.

10.

Kimberlin

D.W.

, Shalabi

, Abzug

M.J.

Safety of oseltamivir compared with the adamantanes in children less than 12 months of age. Pediatr Infect Dis J 2010; 29: 195–198.

11.

Kimberlin

, Acosta

, Sanchez

Oseltamivir (OST) and OST carboxylate (CBX) pharmacokinetics (PK) in infants: interim results from a multicenter trial. 47th Annual Meeting of The Infectious Diseases Society of America. 29 October–1 November 2009, Philadelphia, PA, USA. Abstract 1041.

12.

Acosta

E.P.

, Jester

, Gal

Oseltamivir dosing for influenza infection in premature neonates. J Infect Dis 2010; 202: 563–566.

13.

Scheifele

D.W.

, Halperin

S.A.

Immunization Monitoring Program, Active (IMPACT). An active surveillance system for vaccine safety. Sem Pediatr Infect Dis 2003; 14: 213–219.

14.

Playford

E.G.

, Dwyer

D.E.

Laboratory diagnosis of influenza virus infection. Pathology 2002; 34: 115–125.

15.

Tamiflu (oseltamivir phosphate). Package insert 2011. Roche Products Pty Ltd. (Updated 30 March 2011. Accessed 6 January 2011.) Available from http://www.roche-australia.com/fmfiles/re7229005/downloads/anti-virals/tamiflu-pi.pdf.

16.

Poets

C.F.

When do infants need additional inspired oxygen? A review of the current literature. Pediatr Pulmonol 1998; 26: 424–428.

17.

Advanced Life Support Group. Advanced paediatric life support: the practical approach. 4th Ed. London: BMJ Group 2006.

18.

Department of Attorney General and Justice, State of New South Wales. Health Records and Information Privacy Act, 2002. (Updated 1 September 2009. Accessed 1 July 2010.) Available from http://www.lawlink.nsw.gov.au/lawlink/privacynsw/ll_pnsw.nsf/pages/PNSW_03_hripact.

19.

Iskander

, Kesson

, Dwyer

The burden of influenza in children under 5 years admitted to the Children's Hospital at Westmead in the winter of 2006. J Paediatr Child Health 2009; 45: 698–703.

20.

Lester-Smith

, Zurynski

Y.A.

, Booy

, Festa

M.S.

, Kesson

A.M.

, Elliott

E.J.

The burden of childhood influenza in a tertiary paediatric setting. Commun Dis Intell 2009; 33: 209–215.

21.

Maricich

S.M.

, Neul

J.L.

, Lotze

T.E.

Neurologic complications associated with influenza A in children during the 2003–2004 influenza season in Houston, Texas. Pediatrics 2004; 114: e626–e633.

22.

Morishima

, Togashi

, Yokota

Encephalitis and encephalopathy associated with an influenza epidemic in Japan. Clin Infect Dis 2002; 35: 512–517.

23.

Zarocostas

H1N1 pandemic flu found to cause viral pneumonia in severe cases, says WHO. BMJ 2009; 339: b4313.

24.

Centers for Disease Control and Prevention. Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009–2010 season. (Updated 7 December 2009. Accessed 7 July 2010.) Available from http://www.cdc.gov/h1n1flu/recommendations.htm#table1.